RC’s manuscript, Virtual Pharmacophore Screening Identifies Small-Molecule Inhibitors of the Rev1-CT/RIR Protein-Protein Interaction, is published in ChemMedChem.

The Hadden lab received a grant from the UConn Research Foundation for a project to develop Gli1 inhibitors as anti-cancer agents.